| scholarly article | Q13442814 |
| P2093 | author name string | Donna L Robinson | |
| Hendrik J Vreman | |||
| Erik G Puffenberger | |||
| D Holmes Morton | |||
| Kevin A Strauss | |||
| Graham Hart | |||
| P2860 | cites work | Effect of penicillins on bilirubin-albumin binding | Q68489796 |
| Increase of plasma nonesterified fatty acid concentration and decrease of albumin binding affinity after intravenous injection of glycocholate-lecithin mixed micelles | Q68867673 | ||
| Displacement of bilirubin from adult and newborn serum albumin by a drug and fatty acid | Q69369972 | ||
| Ceftriaxone effect on bilirubin-albumin binding | Q69454887 | ||
| Comparison between two preparations of human serum albumin in treatment of neonatal hyperbilirubinaemia | Q70500477 | ||
| Toxic effects in the Gunn rat of combined treatment with bilirubin and orotic acid | Q70500587 | ||
| Bilirubin-displacing effect of furosemide and sulfisoxazole. An in vitro and in vivo study in neonatal serum | Q71035200 | ||
| Influence of free fatty acids and glucose infusion on serum bilirubin and bilirubin binding to albumin: clinical implications | Q71669047 | ||
| Mapping of the consequences of bilirubin exposure in the immature rat: local cerebral metabolic rates for glucose during moderate and severe hyperbilirubinemia | Q71749485 | ||
| Albumin Reserve for Binding of Bilirubin in Maternal and Cord Serum under Treatment with Sulphasalazine | Q72522627 | ||
| Ceftriaxone--bilirubin-albumin interactions in the neonate: an in vivo study | Q72840540 | ||
| Does ibuprofen affect bilirubin-albumin binding in newborn infant serum? | Q72988824 | ||
| Congenital familial nonhemolytic jaundice with kernicterus | Q73968795 | ||
| Practice patterns in neonatal hyperbilirubinemia | Q73996356 | ||
| A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens | Q74267298 | ||
| Influence of light on the hyperbilirubinaemia of infants | Q77225231 | ||
| Crigler-Najjar syndrome in Saudi Arabia | Q77304074 | ||
| Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns | Q77901611 | ||
| Lessons from the past | Q81377528 | ||
| Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function | Q24564082 | ||
| Determination of the Vacant Amount of High-Affinity Bilirubin Binding Site on Serum Albumin | Q28330549 | ||
| The blood-brain barrier and bilirubin encephalopathy | Q33847807 | ||
| Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation | Q34330809 | ||
| Overview of pediatric liver transplantation | Q35561269 | ||
| In vitro displacement of bilirubin by antibiotics and 2-hydroxybenzoylglycine in newborns | Q35564504 | ||
| Phototherapy: current methods and future directions | Q36027222 | ||
| Bilirubin-albumin binding and neonatal jaundice | Q36027228 | ||
| Risk management of severe neonatal hyperbilirubinemia to prevent kernicterus | Q36074961 | ||
| Bilirubin Displacing Effect of Drugs Used in Neonatology | Q36939656 | ||
| Home phototherapy: use and attitudes among community pediatricians | Q38566203 | ||
| Neonatal bilirubin toxicity. A review of kernicterus and the implications of drug-induced bilirubin displacement | Q39665704 | ||
| Drug-Induced Displacement of Bilirubin from Albumin in the Newborn | Q40157856 | ||
| Neurologic perspectives of Crigler-Najjar syndrome type I. | Q40851763 | ||
| Bilirubin. Solubility and interaction with albumin and phospholipid | Q41498582 | ||
| The future demise of exchange transfusions for neonatal hyperbilirubinemia | Q41554589 | ||
| Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis. | Q42255744 | ||
| Effect of lactate, pyruvate, acetone, acetoacetate, and beta-hydroxybutyrate on albumin binding of bilirubin | Q42258807 | ||
| Bilirubin-displacing effect of ampicillin, indomethacin, chlorpromazine, gentamicin, and parabens in vitro and in newborn infants | Q42259360 | ||
| Unbound Bilirubin in a Term Newborn With Kernicterus | Q43567144 | ||
| Binding of bilirubin and long-chain fatty acids to human serum albumin with general remarks on displacement of firmly bound ligands | Q43691924 | ||
| Effect of hypothermia on bilirubin-induced alterations in brain cell membrane function and energy metabolism in newborn piglets | Q43823155 | ||
| System-based approach to management of neonatal jaundice and prevention of kernicterus | Q43990415 | ||
| Decreased mortality from technical failure improves results in pediatric liver transplantation | Q46269536 | ||
| Treatment of Crigler-Najjar type 1 disease: relevance of early liver transplantation | Q48238424 | ||
| Pediatricians' awareness of and attitudes about four clinical practice guidelines | Q48630517 | ||
| Current therapy for Crigler-Najjar syndrome type 1: report of a world registry | Q48959643 | ||
| Kernicterus in an adult who is heterozygous for Crigler-Najjar syndrome and homozygous for Gilbert-type genetic defect | Q50156621 | ||
| Lack of deafness in Crigler-Najjar syndrome type 1: a patient survey. | Q50506252 | ||
| Binding effect of albumin on uptake of bilirubin by brain. | Q52599062 | ||
| Displacement of bilirubin from albumin by indomethacin | Q67404791 | ||
| The effect of paraben preservatives on albumin binding of bilirubin | Q67791494 | ||
| Effect of Drug Combinations on Bilirubin-Albumin Binding | Q67885461 | ||
| Effect of cephalosporins on bilirubin-albumin binding | Q68259522 | ||
| P433 | issue | 5 | |
| P921 | main subject | bilirubin metabolic disorder | Q390475 |
| P304 | page(s) | 306-319 | |
| P577 | publication date | 2006-01-25 | |
| P1433 | published in | European Journal of Pediatrics | Q15755736 |
| P1476 | title | Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease | |
| P478 | volume | 165 |
| Q97423864 | A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene |
| Q37313599 | A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome |
| Q35954282 | Acute cholangitis in an old patient with Crigler-Najjar syndrome type II - a case report |
| Q27028088 | Amish revisited: next-generation sequencing studies of psychiatric disorders among the Plain people |
| Q37066120 | Application of whole-organ tissue engineering in hepatology |
| Q45728938 | Bilirubin accumulation and Cyp mRNA expression in selected brain regions of jaundiced Gunn rat pups |
| Q42266741 | Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo |
| Q90280901 | Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier |
| Q37333994 | De Novo Donor-Specific HLA Antibody Formation in Two Patients With Crigler-Najjar Syndrome Type I Following Human Hepatocyte Transplantation With Partial Hepatectomy Preconditioning |
| Q44966651 | Disruption of the ugt1 locus in mice resembles human Crigler-Najjar type I disease |
| Q50528431 | Erythrocyte pyruvate kinase deficiency in an old-order Amish cohort: longitudinal risk and disease management. |
| Q36052685 | Evaluating the beneficial and detrimental effects of bile pigments in early and later life |
| Q39012956 | Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment |
| Q95353303 | Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, He |
| Q38260248 | Gene replacement therapy for genetic hepatocellular jaundice |
| Q37015311 | Gene therapy for inborn errors of liver metabolism: progress towards clinical applications |
| Q37945218 | Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives |
| Q48100807 | Germline genetic variants with implications for disease risk and therapeutic outcomes |
| Q37582126 | Helper-Dependent Adenoviral Vectors. |
| Q38025743 | Hepatocyte transplantation for inherited metabolic diseases of the liver. |
| Q48499059 | Hepatocyte transplantation: Consider infusion before incision |
| Q36346898 | Impairment of enzymatic antioxidant defenses is associated with bilirubin-induced neuronal cell death in the cerebellum of Ugt1 KO mice |
| Q42252510 | In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV. |
| Q38872573 | Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management |
| Q41927913 | Liver transplantation for treatment of severe S-adenosylhomocysteine hydrolase deficiency |
| Q43902131 | Living related liver transplantation in Crigler-Najjar syndrome type 1. |
| Q26826934 | New pathophysiological concepts underlying pathogenesis of pigment gallstones |
| Q46934869 | Orlistat treatment of unconjugated hyperbilirubinemia in Crigler-Najjar disease: a randomized controlled trial |
| Q34344245 | Phototherapy device effectiveness in Nigeria: irradiance assessment and potential for improvement |
| Q90012812 | Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome |
| Q38601073 | Progress toward improved therapies for inborn errors of metabolism |
| Q52594620 | Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1. |
| Q36617362 | Recommendations for pregnancies in patients with crigler-najjar syndrome |
| Q30515514 | Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer |
| Q48033678 | Sister Jean Ward, phototherapy, and jaundice: a unique human and photochemical interaction |
| Q36744280 | Stem cell therapy for inherited metabolic disorders of the liver |
| Q41967780 | Successful plasmapheresis for acute and severe unconjugated hyperbilirubinemia in a child with crigler najjar type I syndrome. |
| Q99708873 | The Role of Bilirubin and the Other "Yellow Players" in Neurodegenerative Diseases |
| Q37684677 | Therapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects |
| Q85364981 | Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility |
| Q33586303 | Vector and helper genome rearrangements occur during production of helper-dependent adenoviral vectors |
Search more.